Anzemet (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Anzemet drug offered from sanofi-aventis U.S. LLC. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | dolasetron mesylate |
| SUBSTANCE NAME: | DOLASETRON MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-09-11 |
| END MARKETING DATE: | 0000-00-00 |
Anzemet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Anzemet from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 1997-09-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0088-1202_2af2ca54-c0d7-4b54-91e4-acf6f92e5544 |
| PRODUCT NDC: | 0088-1202 |
| APPLICATION NUMBER: | NDA020623 |
Other DOLASETRON MESYLATE Pharmaceutical Manufacturers / Labelers:
